ApprovalTrail

Ingredient

Ranitidine

Products in Health Canada’s databases that list Ranitidine as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Ranitidine (Ranitidine Hydrochloride)” (93). How names are joined

Drug products
93
19 authorized now
Natural health products
0
0 active licences
Notices of Compliance
4
Products in all
93

Drug products

Authorized products first.

NameDINStatus
MAR-RANITIDINE (150 MG)Marcan Pharmaceuticals Inc. · Status since Nov 201802443708Marketed
MAR-RANITIDINE (300 MG)Marcan Pharmaceuticals Inc. · Status since Nov 201802443716Marketed
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION (150 MG)Pharmascience Inc. · Status since Aug 202402293471Marketed
MINT-RANITIDINE (150 MG)Mint Pharmaceuticals Inc · Status since Oct 202202526379Marketed
MINT-RANITIDINE (300 MG)Mint Pharmaceuticals Inc · Status since Oct 202202526387Marketed
ACID REDUCER (75 MG)Apotex Inc. · Status since Aug 201702230507Dormant
ACID REDUCER (150 MG)Pendopharm Division Of Pharmascience Inc · Status since Jan 200702291282Approved
ACID REDUCER (150 MG)Apotex Inc. · Status since Jul 202002296160Dormant
ACID REDUCER (75 MG)Vita Health Products Inc. · Status since Jun 202102298740Dormant
APO-RANITIDINE (75 MG)Apotex Inc. · Status since Sep 202002280833Dormant
APO-RANITIDINE TABLET 150MG (150 MG)Apotex Inc. · Status since Sep 202000733059Dormant
APO-RANITIDINE TABLET 300MG (300 MG)Apotex Inc. · Status since Sep 202000733067Dormant
JAMP-RANITIDINE (150 MG)JAMP Pharma Corporation · Status since Jul 202102463717Dormant
JAMP-RANITIDINE (300 MG)JAMP Pharma Corporation · Status since Jul 202102463725Dormant
MAXIMUM STRENGTH ACID REDUCER (150 MG)Vita Health Products Inc. · Status since Jun 202102298902Dormant
RAN-RANITIDINE (150 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Jul 202102336480Dormant
RAN-RANITIDINE (300 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Jul 202102336502Dormant
RANITIDINE (150 MG)Sanis Health Inc. · Status since Jul 202102353016Dormant
RANITIDINE (300 MG)Sanis Health Inc. · Status since Jul 202102353024Dormant
ACID REDUCER (75 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602237829Cancelled Post Market
ACID REDUCER (75 MG)Westcan Pharmaceuticals Ltd. · Status since Aug 201702240348Cancelled Pre Market
ACID REDUCER (75 MG)Novopharm Limited · Status since Nov 201502241208Cancelled Pre Market
ACID REDUCER (75.0 MG)Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. · Status since Jul 200402241422Cancelled Post Market
ACID REDUCER (75 MG)Pharmascience Inc. · Status since Jul 202602247551Cancelled Post Market
ACID REDUCER (75 MG)Vita Health Products Inc. · Status since Aug 200902266806Cancelled Post Market
ACID REDUCER (150 MG)Pharmascience Inc. · Status since Oct 202002400103Cancelled Post Market
ACID REDUCER (75 MG)Laboratoire Riva Inc. · Status since May 201902452464Cancelled Post Market
ACID REDUCER MAXIMUM STRENGTH NON-PRESCRIPTION (150 MG)Mylan Pharmaceuticals Ulc · Status since Nov 201602303221Cancelled Pre Market
ACT RANITIDINE (150 MG)Teva Canada Limited · Status since Aug 202002248570Cancelled Post Market
ACT RANITIDINE (300 MG)Teva Canada Limited · Status since Aug 202002248571Cancelled Post Market
AG-RANITIDINE (150 MG)Angita Pharma Inc. · Status since Dec 202102484501Cancelled Post Market
AG-RANITIDINE (300 MG)Angita Pharma Inc. · Status since Dec 202102484528Cancelled Pre Market
BCI RANITIDINE (150 MG)Baker Cummins Inc · Status since Aug 201702265591Cancelled Pre Market
BCI RANITIDINE (300 MG)Baker Cummins Inc · Status since Aug 201702265605Cancelled Pre Market
DOM-RANITIDINE (150 MG)Dominion Pharmacal · Status since May 202502243038Cancelled Post Market
DOM-RANITIDINE (300 MG)Dominion Pharmacal · Status since May 202502243039Cancelled Post Market
M-RANITIDINE (150 MG)Mantra Pharma Inc. · Status since Jul 202202473534Cancelled Post Market
M-RANITIDINE (300 MG)Mantra Pharma Inc. · Status since Jul 202202473542Cancelled Post Market
MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION (150 MG)Dominion Pharmacal · Status since May 202002407523Cancelled Post Market
MYL-RANITIDINE (150 MG)Mylan Pharmaceuticals Ulc · Status since Jun 201602367378Cancelled Post Market
MYL-RANITIDINE (300 MG)Mylan Pharmaceuticals Ulc · Status since Jun 201602367386Cancelled Post Market
MYLAN-RANITIDINE (150 MG)Mylan Pharmaceuticals Ulc · Status since May 201702207761Cancelled Post Market
MYLAN-RANITIDINE (300 MG)Mylan Pharmaceuticals Ulc · Status since May 201702207788Cancelled Post Market
NU-RANIT TAB 150MG (150 MG)Nu-Pharm Inc · Status since Sep 201200865737Cancelled Post Market
NU-RANIT TAB 300MG (300 MG)Nu-Pharm Inc · Status since Sep 201200865745Cancelled Post Market
PHL-RANITIDINE (150 MG)Pharmel Inc. · Status since Sep 200902245782Cancelled Post Market
PHL-RANITIDINE (300 MG)Pharmel Inc. · Status since Sep 200902245783Cancelled Post Market
PMS-RANITIDINE 150 MG (150 MG)Pharmascience Inc. · Status since Jul 202502242453Cancelled Post Market
PMS-RANITIDINE 300 MG (300 MG)Pharmascience Inc. · Status since Jul 202502242454Cancelled Post Market
PRIVA-RANITIDINE (150 MG)Pharmapar Inc. · Status since Jul 202202494310Cancelled Pre Market
PRIVA-RANITIDINE (300 MG)Pharmapar Inc. · Status since Jul 202202494329Cancelled Pre Market
RANITIDINE (150 MG)Pro Doc Limitee · Status since Jul 202300740748Cancelled Post Market
RANITIDINE (300 MG)Pro Doc Limitee · Status since Jul 202300740756Cancelled Post Market
RANITIDINE (75 MG)Pharmascience Inc. · Status since Jul 202602245615Cancelled Pre Market
RANITIDINE (150 MG)Mylan Pharmaceuticals Ulc · Status since Oct 201202286106Cancelled Post Market
RANITIDINE (300 MG)Mylan Pharmaceuticals Ulc · Status since Oct 201202286114Cancelled Post Market
RANITIDINE (150 MG)Sorres Pharma Inc · Status since Jun 201402303353Cancelled Post Market
RANITIDINE (300 MG)Sorres Pharma Inc · Status since Jun 201402303388Cancelled Post Market
RANITIDINE (150 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 201702343436Cancelled Pre Market
RANITIDINE (300 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 201702343444Cancelled Pre Market
RANITIDINE (150 MG)Sivem Pharmaceuticals Ulc · Status since Aug 202202385953Cancelled Post Market
RANITIDINE (300 MG)Sivem Pharmaceuticals Ulc · Status since Aug 202202385961Cancelled Post Market
RANITIDINE INJECTION USP (50 MG)Sandoz Canada Inc. · Status since Mar 202102256711Cancelled Post Market
RANITIDINE NON PRESCRIPTION (150 MG)Sandoz Canada Inc. · Status since Jun 201702368005Cancelled Pre Market
RANITIDINE TABLETS (150 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Jul 202502350203Cancelled Pre Market
RANITIDINE TABLETS (300 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Jul 202502350211Cancelled Pre Market
RANITIDINE TABLETS 150MG (150 MG)Prempharm Inc. · Status since Aug 200502230003Cancelled Post Market
RANITIDINE TABLETS 300MG (300 MG)Prempharm Inc. · Status since Aug 200502230004Cancelled Post Market
RATIO-RANITIDINE (150 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 201400828823Cancelled Post Market
RATIO-RANITIDINE (300 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 201400828688Cancelled Post Market
RIVA-RANITIDINE 150 (150 MG)Laboratoire Riva Inc. · Status since Sep 201902247814Cancelled Post Market
RIVA-RANITIDINE 300 (300 MG)Laboratoire Riva Inc. · Status since Sep 202002247815Cancelled Post Market
RIVA-RANITIDINE 75MG (75 MG)Laboratoire Riva Inc. · Status since Jun 201702238579Cancelled Post Market
SANDOZ RANITIDINE (150 MG)Sandoz Canada Inc. · Status since Mar 202102243229Cancelled Post Market
SANDOZ RANITIDINE (300 MG)Sandoz Canada Inc. · Status since Mar 202102243230Cancelled Post Market
SCHEINPHARM RANITIDINE 150 MG (150 MG)Pharmascience Inc. · Status since Sep 201402241598Cancelled Post Market
SCHEINPHARM RANITIDINE 300 MG (300 MG)Pharmascience Inc. · Status since Sep 201402241599Cancelled Post Market
TEVA-RANITIDINE (300 MG)Teva Canada Limited · Status since Jun 201800828556Cancelled Post Market
TEVA-RANITIDINE (150 MG)Teva Canada Limited · Status since Jun 201800828564Cancelled Post Market
TEVA-RANITIDINE INJECTION (25 MG)Teva Canada Limited · Status since Oct 201502231487Cancelled Pre Market
TEVA-RANITIDINE SOLUTION (75 MG)Teva Canada Limited · Status since Jun 202002242940Cancelled Post Market
TRIA-RANITIDINE 150MG TABLET (150 MG)Laboratoires Trianon Inc. · Status since Jan 201602229562Cancelled Pre Market
TRIA-RANITIDINE 300MG TABLET (300 MG)Laboratoires Trianon Inc. · Status since Jan 201602229563Cancelled Pre Market
ZANTAC (150 MG)Glaxosmithkline Inc · Status since Sep 201702212331Cancelled Post Market
ZANTAC (300 MG)Glaxosmithkline Inc · Status since Sep 201702212358Cancelled Post Market
ZANTAC (50 MG)Glaxosmithkline Inc · Status since Aug 201802212366Cancelled Post Market
ZANTAC (15 MG)Glaxosmithkline Inc · Status since Feb 201202212374Cancelled Post Market
ZANTAC (75 MG)Sanofi Consumer Health Inc · Status since Feb 202202230287Cancelled Post Market
ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION (150 MG)Sanofi Consumer Health Inc · Status since Feb 202202277301Cancelled Post Market
ZANTAC TAB 150MG (150 MG)Glaxo Canada Inc · Status since Aug 200000553379Cancelled Post Market
ZANTAC TAB 300MG (300 MG)Glaxo Canada Inc · Status since Aug 200000641790Cancelled Post Market
ZANTAC-C CAP 150MG (150 MG)Glaxo Canada Inc · Status since Jul 199800849421Cancelled Post Market
ZANTAC-C CAP 300MG (300 MG)Glaxo Canada Inc · Status since Jul 199800849448Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.